Sanofi (SAN) News Today €97.92 +2.02 (+2.11%) As of 05/2/2025 Add Compare Share Share Headlines Stock AnalysisChartHeadlinesSustainabilityBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Special Le Mans livery for UA McLarenMay 2 at 5:52 AM | msn.comMuthoot Finance, Sanofi India to trade ex-dividend today; Ami Organics to trade ex-split todayApril 25, 2025 | msn.comAnalysts Offer Insights on Healthcare Companies: Sanofi (OtherSNYNF), Roche Holding AG (OtherRHHVF) and BioNTech SE (BNTX)April 25, 2025 | markets.businessinsider.comDividend Stocks in Focus: Sanofi India, Muthoot Finance trade ex-dividend; Ami Organics trades ex-splitApril 25, 2025 | msn.comRoche and Sanofi Seek Ways to Sidestep Potential Trump TariffsApril 25, 2025 | msn.comEuropean pharma companies push for higher drug prices in EU amid U.S. tariff threatsApril 24, 2025 | msn.comSanofi's quarterly profit boosted by Dupixent and newer drugs; forecast unchangedApril 24, 2025 | msn.comFDA Approves Dupixent for Chronic Spontaneous UrticariaApril 23, 2025 | usnews.comPharma bosses call for higher drug prices in EU to counter tariff threatApril 23, 2025 | ft.comSanofi Should Report Lower Profit, Sales Amid U.S. Policy Uncertainty -- Earnings PreviewApril 22, 2025 | marketwatch.comSanofi Canada is investing in care for the planetApril 22, 2025 | theglobeandmail.com1170% dividend per share: Record date this week - Do you own the BSE 500 stock?April 20, 2025 | msn.comMuthoot Finance, Sanofi India among 9 stocks going ex-dividend, split next week. Are they on your radar?April 20, 2025 | msn.comRegeneron, Sanofi Get FDA Approval For Dupixent in Skin Disease CSUApril 18, 2025 | marketwatch.comEarendil Labs Sanofi Ink Global License Deal for Next Gen Autoimmune TherapiesApril 18, 2025 | msn.comPress Release: Sanofi’s respiratory pipeline advances with new data in asthma and plans for new clinical studies in COPDApril 15, 2025 | markets.businessinsider.comFinal dividend of Rs 55 announced by company after demerger; record date preponedApril 13, 2025 | msn.comSanofi announces publication of tolebrutinib Phase 3 data in NEJMApril 9, 2025 | markets.businessinsider.comDeutsche Bank Sticks to Their Hold Rating for Sanofi (SNYNF)April 7, 2025 | markets.businessinsider.comHealth Ministry, Sanofi strengthen cooperation in pharmaceutical industry developmentApril 6, 2025 | msn.comFDA awards ODD status to Sanofi’s rilzabrutinib for two rare conditionsApril 4, 2025 | finance.yahoo.comSanofi-Novavax deal in jeopardy as FDA halts vaccine approvalApril 4, 2025 | msn.comBernstein Sticks to Their Buy Rating for Sanofi (SNYNF)April 3, 2025 | markets.businessinsider.comSanofi Says Rilzabrutinib Granted Orphan Drug Designation in the U.S.April 3, 2025 | marketwatch.comNurix Therapeutics announces Sanofi exclusively licensed a programApril 2, 2025 | markets.businessinsider.comLeqembi’s EU review drags on; Sanofi gets a new development headApril 2, 2025 | yahoo.comSanofi: Qfitlia Approval A Bright Spot As Landscape Darkens For European PharmaApril 2, 2025 | seekingalpha.comSanofi with We Are ILL, Inc. Rings the Opening BellApril 1, 2025 | nasdaq.comIs Sanofi (SNY)the Best Gene-Editing Stock to Buy?April 1, 2025 | msn.comBanks Sell €7.45 Billion of Debt for CD&R Sanofi Unit BuyoutApril 1, 2025 | bloomberg.comExpanding early type 1 diabetes risk detection using digital healthMarch 31, 2025 | usatoday.comSanofi: Qfitlia approved as the first therapy in the US to treat hemophilia A or B with or without inhibitorsMarch 29, 2025 | finanznachrichten.deSanofi Qfitlia approved as the first therapy in the US to treat hemophilia A or B with or without inhibitorsMarch 28, 2025 | finanznachrichten.deSanofi’s Easier to Use Hemophilia Drug Approved by US FDAMarch 28, 2025 | msn.comSanofi Dupixent approved as the first-ever biologic medicine in Japan for patients with COPDMarch 28, 2025 | finanznachrichten.deSanofi: Chlamydia vaccine candidate granted fast track designation by the US FDAMarch 26, 2025 | finanznachrichten.deSanofi Chlamydia vaccine candidate granted fast track designation by the US FDAMarch 26, 2025 | finanznachrichten.deSanofi: Tolebrutinib regulatory submission accepted for priority review in the US for patients with multiple sclerosisMarch 25, 2025 | finanznachrichten.deSanofi Tolebrutinib regulatory submission accepted for priority review in the US for patients with multiple sclerosisMarch 25, 2025 | finanznachrichten.deSanofi Availability of the Q1 2025 Aide mémoireMarch 24, 2025 | finanznachrichten.deSanofi outlays $1.9bn to purchase Dren Bio’s bispecific antibodyMarch 21, 2025 | msn.comBanks Launch €7.45 Billion Debt Sale for Sanofi Unit BuyoutMarch 21, 2025 | bloomberg.comPress Release: Sanofi to acquire Dren Bio’s bispecific myeloid cell engager for deep B-cell depletion, broadening immunology pipelineMarch 20, 2025 | markets.businessinsider.comSanofi strikes autoimmune drug deal for up to $1.9BMarch 20, 2025 | msn.comSanofi Agrees US Autoimmune Drug Deal for Up to $1.9 BillionMarch 20, 2025 | msn.comJaguars LB Chad Muma opens up on playing in the NFL with Type 1 DiabetesMarch 20, 2025 | msn.comDividend Rs 55 by pharma company; record date in AprilMarch 18, 2025 | msn.comBanks Aim to Sell €8.65 Billion Sanofi Buyout Debt Next WeekMarch 18, 2025 | bloomberg.comSanofi: Dupixent late-breaking positive pivotal data in bullous pemphigoid presented at AADMarch 15, 2025 | finanznachrichten.deSanofi starts annual production of vaccines for 2025-26 flu seasonMarch 14, 2025 | markets.businessinsider.com Get Sanofi News Delivered to You Automatically Sign up to receive the latest news and ratings for SAN and its competitors with MarketBeat's FREE daily newsletter. Email Address SAN Media Mentions By Week SAN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SAN News Sentiment▼0.380.83▲Average Medical News Sentiment SAN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SAN Articles This Week▼15▲SAN Articles Average Week Get Sanofi News Delivered to You Automatically Sign up to receive the latest news and ratings for SAN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Deutsche Bank Aktiengesellschaft News Today Bayer Aktiengesellschaft News Today Fielmann Group News Today Fresenius SE & Co. KGaA News Today Genfit News Today Sartorius Stedim Biotech News Today Merck KGaA News Today Siemens Healthineers News Today Sartorius Aktiengesellschaft News Today Fresenius Medical Care News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (EPA:SAN) was last updated on 5/3/2025 by MarketBeat.com Staff From Our PartnersElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | SponsoredHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredTrump to solve American wealth loss?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredReal Americans Don’t Wait on Wall Street’s Next MoveWhat's happening in the markets right now should concern every freedom-loving American who's worked hard and s...Premier Gold Co | SponsoredThe collapse has already startedThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sanofi Please log in to your account or sign up in order to add this asset to your watchlist. Share Sanofi With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SAN Stock Free SAN Stock Alerts